About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT04278495

The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

Previous experimental studies concluded that angiotensin receptor blockers can ameliorate the harmful inflammatory and histological changes after relief of obstruction. Nevertheless, these witnessed e...

Lead sponsor: Mansoura University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mansoura University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•anuric and oliguric patients
•calculuar ureteral obstruction

Exclusion Criteria

•anomalous kidney
•bilateral obstructed kidney
•history of recent use of angiotensin receptor blockers or angiotensin-converting enzyme inhibitors
•ASA score of \>3

Related studies

RECRUITINGPhase 2

Intravesical Aminophylline for Urgent Ureteral Stenting in Acute Calculous Anuria

NCT07617948 · Acute Calculous Anuria, Ureteral Calculi, and more

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

NCT06389721 · Chemotherapy-induced Peripheral Neuropathy

Feasibility and Clinical Utility of Paired Non-Invasive Hemodynamic and Tissue Oximetry Monitoring to Detect Limb Ischemia in Lithotomy-Positioned Surgeries

NCT07387653 · Neuropathy;Peripheral, Limb Ischemia

Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPN

NCT07576179 · Diabetic Peripheral Neuropathy (DPN)

RECRUITINGPhase 3

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141 · Chronic Inflammatory Demyelinating Polyneuropathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 20, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment96

Start dateSep 2014

Last updatedFeb 20, 2020

Condition

Losartan Adverse Reaction Uropathy Uropathy Obstructive

Locations shown

Urology and nephrology center

Al Mansurah, Outside U.S./Canada

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 20, 2020Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions